EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Urine Proteomic Profiling at Admission Reveals Complement Biomarkers Linked to Alcohol‐Associated Liver Disease

Luan Prado, Ryan Musich, Moyinoluwa Taiwo, Vai Pathak, Daniel M Rotroff, Annette Bellar, Nicole Welch, Jaividhya Dasarathy, David Streem, AlcHepNet, Srinivasan Dasarathy iD, Laura E Nagy

Alcohol, Clinical and Experimental Research · 2026

DOI: 10.1111/acer.70353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, 2026. Verfasst von Luan Prado und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Proteomics, Liver Diseases, Alcoholic, Hepatitis, Alcoholic, Complement System Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAAA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Circulating complement is associated with occurrence of alcohol‐associated hepatitis (AH) and is a potential biomarker to distinguish AH from alcohol cirrhosis (AC). Complement contributes to kidney injury, a condition often occurring in patients with alcohol‐associated liver disease (ALD). However, little is known regarding complement in cross talk between liver and kidney in ALD. Here, we tested the hypothesis that urinary complement would provide potential biomarkers for ALD and insights into mechanisms of liver–kidney cross talk in the pathogenesis of ALD.

Methods

Plasma and urine were collected at admission from patients with severe alcoholic hepatitis (sAH), healthy controls (HC), and heavy drinkers without liver disease (HD) (from the multicenter Alcohol Hepatitis Network) and with AC (from the Northern Ohio Alcohol Center). Urine was subjected to unbiased proteomics analysis and plasma complement assessed by multiplex/ELISA assays. Thirty‐ and 90‐day mortality was tracked in patients with sAH.

Results

All three complement activation pathways were perturbed in plasma and urine of patients with sAH and AC compared to HC and HD. Components of the lectin and classical pathways in urine were associated with 30‐ and 90‐day mortality in patients with sAH. When four complement proteins were combined, they distinguished sAH from AC (AUC 0.78), equivalent to that of model for end‐stage liver disease (MELD) (AUC 0.65). There was no correlation between complement in plasma and urine, suggesting an independent impact of sAH on complement in kidney and liver.

Conclusion

The urinary proteome revealed complement protein signatures associated with sAH and AC, providing valuable insights into the potential for complement biomarkers and the mechanisms of liver–kidney cross talk in ALD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsLiver Diseases, AlcoholicHepatitis, AlcoholicComplement System ProteinsHumansBiomarkersMaleFemaleMiddle AgedAdultAged

Stichwörter der Autor:innen

ALDalcohol cirrhosisalcohol‐associated hepatitiscomplement

Substanzen

BiomarkersComplement System Proteins

Autor:innen und Institutionen

  • Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
  • Endocrine and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Center for Quantitative Metabolic Research, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Family Medicine, Metro Health Medical Center, Cleveland, Ohio, USA.

ORCID-Profile: Srinivasan Dasarathy

Förderung

  • NIH HHS
  • NIAAA NIH HHS
  • National Institutes of Health

Zitieren

APA

Prado, L., Musich, R., Taiwo, M., Pathak, V., Rotroff, D. M., Bellar, A., Welch, N., Dasarathy, J., Streem, D., AlcHepNet, Dasarathy, S., & Nagy, L. E. (2026). Urine Proteomic Profiling at Admission Reveals Complement Biomarkers Linked to Alcohol‐Associated Liver Disease. Alcohol, Clinical and Experimental Research. https://doi.org/10.1111/acer.70353

Vancouver

Prado L, Musich R, Taiwo M, Pathak V, Rotroff DM, Bellar A, et al. Urine Proteomic Profiling at Admission Reveals Complement Biomarkers Linked to Alcohol‐Associated Liver Disease. Alcohol, Clinical and Experimental Research. 2026. doi:10.1111/acer.70353

BibTeX
@article{Prado2026,
  author = {Prado, Luan and Musich, Ryan and Taiwo, Moyinoluwa and Pathak, Vai and Rotroff, Daniel M and Bellar, Annette and Welch, Nicole and Dasarathy, Jaividhya and Streem, David and AlcHepNet, AlcHepNet and Dasarathy, Srinivasan and Nagy, Laura E},
  title = {Urine Proteomic Profiling at Admission Reveals Complement Biomarkers Linked to Alcohol‐Associated Liver Disease},
  journal = {Alcohol, Clinical and Experimental Research},
  year = {2026},
  doi = {10.1111/acer.70353}
}
Kostenlos starten →